Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Trajan Group HoldingsASX:TRJ -10.34%38 EV-to-FCF is 61.63 as of Jul. 14, 2026, which is 185% above its 10-year median of 21.60. GuruFocus rates ASX:TRJ with a GF Score™ of 38/100 and a GF Value™ of A$1.11 (Possible Value Trap). The stock has 2 warning signs investors should review. Among 414 Medical Devices & Instruments companies, Trajan Group Holdings ranks worse than 81.4% on this metric.
EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Trajan Group Holdings's Enterprise Value is A$89.7 Mil.
Trajan Group Holdings's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2025 was A$1.5 Mil. Therefore, Trajan Group Holdings's EV-to-FCF for today is 61.63.
The historical rank and industry rank for Trajan Group Holdings's EV-to-FCF or its related term are showing as below:
ASX:TRJ'
s EV-to-FCF Range Over the Past 10 Years
Min: -549.49 Med: 21.6 Max: 336.59
Current: 61.63
During the past 5 years, the highest EV-to-FCF of Trajan Group Holdings was 336.59. The lowest was -549.49. And the median was 21.60.
ASX:TRJ's EV-to-FCF is ranked worse than 81.4% of 414
companies
in the Medical Devices & Instruments industry
Industry Median: 23.445
vs ASX:TRJ: 61.63
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Trajan Group Holdings (ASX:TRJ) EV-to-FCF Explanation
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Trajan Group Holdings's PE Ratio (TTM) for today is calculated as:
Trajan Group Holdings's share price for today is A$0.26.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Trajan Group Holdings's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 was A$-0.009.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Instruments & Supplies subindustry, Trajan Group Holdings's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Trajan Group Holdings EV-to-FCF vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Trajan Group Holdings's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where Trajan Group Holdings's EV-to-FCF falls into.
Trajan Group Holdings's current Enterprise Value is A$89.7 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Trajan Group Holdings's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2025 was A$1.5 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Trajan Group Holdings (ASX:TRJ) has a EV-to-FCF of 61.63 as of Jul. 14, 2026. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Trajan Group Holdings and its competitors. This is 185% above median its historical median of 21.60. According to the industry distribution chart, Trajan Group Holdings ranks #337 out of 414 companies in the Medical Devices & Instruments industry, placing it in the top 81.4%.
Is Trajan Group Holdings' EV-to-FCF too high?
Trajan Group Holdings' current EV-to-FCF of 61.63 is 185% above median its 10-year median of 21.60. The Medical Devices & Instruments industry median EV-to-FCF is 23.45. Trajan Group Holdings' value of 61.63 is 162.9% above this industry median. Based on the distribution chart, Trajan Group Holdings ranks #337 out of 414 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Trajan Group Holdings has a GF Score™ of 38/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Trajan Group Holdings' EV-to-FCF compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Trajan Group Holdings ranks #337 out of 414 companies for EV-to-FCF. This places Trajan Group Holdings in the lower half of its industry. The industry median EV-to-FCF is 23.45. Trajan Group Holdings' value of 61.63 is 162.9% above this benchmark. While the company's 10-year median is 21.60 vs. the industry median of 23.45, Trajan Group Holdings has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-FCF for a Medical Devices & Instruments company?
The median EV-to-FCF among Medical Devices & Instruments companies is 23.45, based on 414 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-FCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-FCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Trajan Group Holdings's current EV-to-FCF of 61.63 is 162.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-FCF mean?
A high EV-to-FCF can signal that a stock is expensive relative to its fundamentals. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Trajan Group Holdings and its competitors. For the Medical Devices & Instruments industry, the median EV-to-FCF is 23.45 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Trajan Group Holdings's current EV-to-FCF is 61.63, which is 185% above median its own 10-year median of 21.60. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Trajan Group Holdings stock overvalued right now?
Based on GuruFocus' analysis, Trajan Group Holdings (ASX:TRJ) is currently considered Possible Value Trap. The stock's GF Value™ is A$1.11, compared to a current price of A$0.26 — trading 76.6% below its estimated fair value. The current EV-to-FCF is 61.63, which is 185% above median its 10-year median of 21.60 and 162.9% above the Medical Devices & Instruments industry median of 23.45. Trajan Group Holdings' overall GF Score™ is 38/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-FCF calculated?
EV-to-FCF is calculated from a company's financial statements. For Trajan Group Holdings (ASX:TRJ), the current EV-to-FCF is 61.63 as of Jul. 14, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Trajan Group Holdings (ASX:TRJ) Overvalued in 2026?
Based on GuruFocus' analysis, Trajan Group Holdings stock appears to be undervalued.
The current stock price of A$0.26 is trading 76.6% below its estimated GF Value™ of A$1.11.
GuruFocus considers Trajan Group Holdings to be Possible Value Trap.
Key valuation signals for ASX:TRJ:
EV-to-FCF: 61.63 (185% above median its 10-year median of 21.60)
GF Value™: A$1.11 vs. price of A$0.26 (76.6% below fair value)
Industry Position: 162.9% above the Medical Devices & Instruments median (#337 of 414)
No single metric tells the full story. See the ASX:TRJ stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Trajan Group Holdings Ltd is a developer and manufacturer of analytical and life sciences products and devices, seeking to enrich human well-being through scientific measurement. Its current portfolio of products comprises products, devices and solutions that are used in the analysis of biological, food, and environmental samples. The Group now reports in three operating segments: Components and Consumables, Capital Equipment and Disruptive Technologies. Key revenue is generated from Components and consumables, which include parts, supplies, components, and consumable products worldwide. The Group operates in Asia (Malaysia, Japan and Australia and New Zealand (ANZ)), USA and Europe, Middle East, Africa, and India (EMEA).
38GF Score
Get the complete analysis for ASX:TRJ
EV-to-FCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ASX:TRJ has been successfully added to your 
